Ono Pharmaceutical Co Ltd

CSR Report

Report overview

The report describes ONO's materiality process and priority sustainability issues, including selected SDG contributions. For FY2019, it reports a 8.4% reduction in market-based Scope 1 and 2 GHG emissions compared with FY2017 and a renewable energy usage rate of 11.2%. It also details water-use reduction, resource-recycling activities and human-rights due diligence. Sustainability information in the report received limited assurance from Deloitte Tohmatsu Sustainability Co., Ltd. under ISAE 3000 and ISAE 3410.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019-2020
Period: 1 April 2019 – 31 March 2020
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Energy consumption
Renewable energy
Water consumption
Waste
Employees
Women on the board
Women in management
Net zero target

Materiality

Assessment
Basis
Matrix

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services